1. Home
  2. VHC vs THAR Comparison

VHC vs THAR Comparison

Compare VHC & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$22.03

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Tharimmune Inc.

THAR

Tharimmune Inc.

HOLD

Current Price

$2.60

Market Cap

83.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
THAR
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
83.1M
IPO Year
1999
2022

Fundamental Metrics

Financial Performance
Metric
VHC
THAR
Price
$22.03
$2.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
14.6K
499.6K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2020.00
N/A
52 Week Low
$3.68
$0.95
52 Week High
$29.00
$9.08

Technical Indicators

Market Signals
Indicator
VHC
THAR
Relative Strength Index (RSI) 53.08 46.50
Support Level $18.21 $2.36
Resistance Level $23.70 $2.55
Average True Range (ATR) 1.92 0.20
MACD -0.33 0.01
Stochastic Oscillator 56.77 65.60

Price Performance

Historical Comparison
VHC
THAR

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: